Abstract
Venous drainage from the retina merges into the central retinal vein and can be obstructed in the branch veins that drain the retinal quadrants, or the central retinal vein itself, which are termed Branch Retinal Vein Occlusion (BRVO) and Central Retinal Vein Occlusion (CRVO), respectively. Obstruction of retinal venous drainage often leads to a sudden or progressive increase in distal venous and capillary pressure with loss of vision and visual field defects. The extent of visual impairment correlates with the location and severity of the venous occlusion and how it impacts perfusion in the retina. Macular edema or retinal ischemia secondary to retinal vein occlusion is responsible for vision loss in retinal vein occlusions, and the advent of anti-VEGF therapeutics has revolutionized the management of vascular disease in the retina.
In this chapter, we review our current understanding of retinal vein occlusions and how OCT-Angiography (OCT-A) is being used clinically in the diagnosis and management of obstructive venous vascular phenomena. The benefits of using OCT-A in the diagnosis and management of CRVO and BRVO over conventional approaches, such as Fundus Fluorescein Angiography (FFA), are discussed. The current limitations of OCT-A and recent advances in the technology are also covered here. Finally, we assess how OCT-A can play a role in the development of new therapeutics to tackle one of the major causes of vision loss worldwide.